Related Experiment Video
Updated: Jun 6, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
Neural Interoceptive Processing Is Modulated by Deep Brain Stimulation to Subcallosal Cingulate Cortex for
Elisa Xu1, Samantha Pitts2, Jacob Dahill-Fuchel3
1Nash Family Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
Subcallosal cingulate deep brain stimulation (SCC DBS) improved interoceptive processing in patients with treatment-resistant depression. This enhancement in bodily sensation processing correlated with faster antidepressant responses.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Devices
Background:
- Depression is linked to altered processing of internal bodily sensations (interoception).
- Subcallosal cingulate deep brain stimulation (SCC DBS) is a treatment for resistant depression with known effects on bodily sensations.
- The targeted brain region for SCC DBS is connected to areas crucial for interoception.
Purpose of the Study:
- To investigate if SCC DBS influences cortical interoceptive processing in patients with treatment-resistant depression.
- To explore the relationship between changes in interoception and depression treatment outcomes.
Main Methods:
- Electroencephalography (EEG) was used to measure heartbeat-evoked potentials (HEP), a neural marker of interoception.
- HEP was recorded in 8 patients before and up to 6 months after SCC DBS implantation.
- The immediate effects of DBS (on vs. off) and correlation of HEP changes with depression outcomes were analyzed.
Main Results:
- Heartbeat-evoked potential (HEP) amplitude significantly increased over 6 months of SCC DBS treatment.
- Increased HEP amplitude was associated with a faster antidepressant response.
- DBS stimulation had an immediate effect on HEP, particularly over the left parietal cortex.
Conclusions:
- SCC DBS appears to modulate neural interoception in treatment-resistant depression.
- These findings support the hypothesis that interoceptive mechanisms play a role in the efficacy of DBS for depression.
- The study provides brain-based evidence linking interoception and depression treatment via DBS.
More Related Videos
08:25Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans
Published on: May 19, 2016
07:12Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021